Advanced Biomed Inc. (ADVB): who owns it and who trades it
As of Nov 12, 2026, no open-market insider purchases or sales of ADVB were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
No ADVB insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ADVB short interest
Low short interest. 0.7% of ADVB shares are sold short: about 1 share in 147. Over the last 12 reports the number of shares short went up 202%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 11,238 ADVB shares were sold short, 0.7% of the shares outstanding, up 15.3% from the report before. At the average daily volume of 56,323 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 11,238 | 0.68% | +15% | 56,323 | 1.0 |
| Oct 15, 2026 | 9,747 | 0.59% | -48% | 16,412 | 1.0 |
| Sep 30, 2026 | 18,897 | 1.37% | +92% | 22,487 | 1.0 |
| Sep 15, 2026 | 9,845 | 0.71% | -40% | 110,241 | 1.0 |
| Aug 31, 2026 | 16,357 | 1.18% | -56% | 272,520 | 1.0 |
| Aug 14, 2026 | 37,364 | 2.70% | -35% | 231,612 | 1.0 |
| Jul 31, 2026 | 57,213 | 4.14% | +441% | 8.64M | 1.0 |
| Jul 15, 2026 | 10,571 | 0.76% | -31% | 16,434 | 1.0 |
| Jun 30, 2026 | 15,397 | 1.11% | +73% | 14,727 | 1.1 |
| Jun 15, 2026 | 8,876 | 0.64% | +356% | 35,930 | 1.0 |
| May 29, 2026 | 1,945 | 0.14% | -48% | 43,697 | 1.0 |
| May 15, 2026 | 3,722 | 0.27% | -72% | 522,925 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Advanced Biomed company events
Advanced Biomed filed 14 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, listing). The latest was on Jul 17, 2026.
- Jul 17, 2026AgreementEnded an important agreement. Filing
- Jul 1, 2026VoteReported shareholder vote results. Filing
- Jun 30, 2026AgreementAdvanced Biomed Inc. entered into a Share Purchase Agreement with an unrelated third party, pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed Inc. (Taiwan), a company organized under the laws of Taiwan (the Republic of China) and a… Filing
- May 1, 2026LeadershipThe Company has determined to undertake a significant strategic pivot, transitioning its primary business focus from life sciences to artificial intelligence development. Filing
- Apr 14, 2026AgreementAdvanced Biomed Inc. entered into a Loan Agreement with Jie Wang, pursuant to which the Lender lent to the Company a principal amount of Six Hundred Thousand United States Dollars (US$600,000). Filing
- Apr 3, 2026AgreementAdvanced Biomed Inc. entered into a Share Purchase Agreement with Acellent Technologies (Hong Kong) Co. Limited and the sole shareholder of the Target, pursuant to which the Company agreed to purchase from Seller 100% of the equity interest in the Target. Filing
- Mar 30, 2026LeadershipResignation of Director and Chief Technology Officer. Filing
- Mar 16, 2026AnnouncementOther Event As previously disclosed, on July 18, 2025, Advanced Biomed Inc. received a written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC notifying the Company that the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement… Filing
- Feb 26, 2026SharesChanged the rights of its shareholders. Filing
- Feb 10, 2026SharesAmended an earlier report. Sold new shares outside a public offering. Filing
- Feb 2, 2026AgreementAdvanced Biomed Inc., a Nevada Corporation, entered into a securities purchase agreement with certain investors relating to the issuance and sale of 4,000,000 shares of common stock, par value $0.001 per share, of the Company, at $0.062 per share for a total purchase price of $248,000. Filing
- Jan 27, 2026AgreementAs previously disclosed on the Current Report on Form 8-K of Advanced Biomed Inc., on December 23, 2025, the Company entered into an agreement with an unrelated third party, Wei Ha Hui, pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK)… Filing
- Jan 21, 2026ListingAs previously disclosed, on July 18, 2025, Advanced Biomed Inc. received a written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC notifying the Company that the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for… Filing
- Dec 30, 2025DealCompleted a purchase or sale of a business or assets. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Advanced Biomed financials
Famous investors that hold ADVB
1 of the 50 well-known investors we track reported holding ADVB in their latest 13F filing. The largest position is Jim Simons's, worth $65.4K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 10,500 | $65.4K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Advanced Biomed Inc. (ADVB) stock
Are ADVB insiders buying or selling?
No ADVB insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in ADVB?
As of Oct 30, 2026, 11,238 ADVB shares were sold short, 0.7% of the shares outstanding, up 15.3% from the report before. At the average daily volume of 56,323 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold ADVB?
1 of the 50 well-known investors we track reported ADVB in their latest 13F filing, including Jim Simons. The largest position is worth $65.4K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.